Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease-Reference-Cited by-同舟云学术

Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease

Published:2018-06 Issue:26 Volume:293 Page:10026-10040
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Knight J. Morgan,Mandal Pijus,Morlacchi Pietro,Mak Garbo,Li Evan,Madison Matthew,Landers Cameron,Saxton Brandon,Felix Ed,Gilbert Brian,Sederstrom Joel,Varadhachary Atul,Singh Melissa M.,Chatterjee Dev,Corry David B.^ORCID,McMurray John S.

Funder

HHS | National Institutes of Health (NIH)

American Asthma Foundation (AAF)

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference63 articles.

1. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma;Hammad;Nat. Rev. Immunol,2008

2. Early local immune defences in the respiratory tract;Iwasaki;Nat. Rev. Immunol,2017

3. Type 2 inflammation in asthma: present in most, absent in many;Fahy;Nat. Rev. Immunol,2015

4. Severe asthma: current management, targeted therapies and future directions: a roundtable report;McDonald;Respirology,2017

5. Biomarkers of airway type-2 inflammation and integrating complex phenotypes to endotypes in asthma;Peters;Curr. Allergy Asthma Rep,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STATs, promising targets for the treatment of autoimmune and inflammatory diseases;European Journal of Medicinal Chemistry;2024-11

2. The JAK-STAT pathway: from structural biology to cytokine engineering;Signal Transduction and Targeted Therapy;2024-08-21

3. Small molecule drug discovery targeting the JAK-STAT pathway;Pharmacological Research;2024-06

4. Aerobic physical training reduces severe asthma phenotype involving kinins pathway;Molecular Biology Reports;2024-04-10

5. Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond;Trends in Immunology;2024-02